News & Media
News Wire
Tue., February 9, 2010
Communication breakdown: what happens to nerve cells in Parkinson’s disease
A new study from The Montreal Neurological Institute and Hospital – The Neuro - at McGill University is the first to discover a molecular link between Parkinson’s disease and defects in the ability of nerve cells to communicate. The study, published in the prestigious journal Molecular Cell and selected as Editor’s Choice in the prominent journal Science, provides new insight into the... Read more
Mon., February 1, 2010
Double agent: glial cells can protect or kill neurons, vision
Scientists have identified a double agent in the eye that, once triggered, can morph from neuron protector to neuron killer. The discovery has significant health implications since the neurons killed through this process results in vision loss and blindness.
Wed., December 16, 2009
20 McGill research projects get CFI boost
McGill University welcomed today the Canada Foundation for Innovation’s (CFI) investment of $3,911,390 earmarked to support 20 outstanding research initiatives.
Thu., September 10, 2009
Brenda Milner wins international Balzan Prize
Dr. Brenda Milner, the Dorothy J. Killam Professor at the Montreal Neurological Institute, McGill University, is one of four recipients of the prestigious International Balzan Prize for 2009. Each awardee will receive approximately $1 million CDN (one million swiss francs), half of which must be designated for research. The announcement was made by the Balzan Foundation Monday in Milan, Italy.
Wed., August 19, 2009
Physicians at The Neuro first in North America to offer a new stent for patients with intracranial aneurysms
A new and advanced technology is now available to patients with large, broad neck intracranial aneurysms. Physicians at the Montreal Neurological Institute and Hospital (The Neuro) at the McGill University Health Centre and McGill University were the first in North America to implant a specialized intracranial stent, providing innovative treatment for intracranial aneurysms.
Tue., June 9, 2009
Amyotrophic Lateral Sclerosis (ALS) Fact Sheet
About ALS Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a devastating neurodegenerative disease affecting between two and five people per 100,000. Approximately 2,500 - 3,000 Canadian adults currently live with ALS. 80% per cent of people with ALS die within two to five years of diagnosis. The major symptoms of ALS are muscle weakness and wasting, progressively... Read more
Tue., May 26, 2009
“Thinking Ahead” for MS
Scotiabank today announced a donation of $500,000 to the Montreal Neurological Institute and Hospital’s (The Neuro) “Thinking Ahead” campaign, which will expand the hospital’s Multiple Sclerosis (MS) Clinic. The expanded facility will result in improved service and care for people with MS.
Mon., May 25, 2009
One size does not fit all: A new look at therapies
Statins, a commonly prescribed class of drugs used by millions worldwide to effectively lower blood cholesterol levels, may actually have a negative impact in Multiple Sclerosis (MS) patients treated with high daily dosages.
Tue., May 19, 2009
Cocaine: Perceived as a reward by the brain?
Cocaine is one of the oldest drugs known to humans, and its abuse has become widespread since the end of the 19th century. At the same time, we know rather little about its effects on the human brain or the mechanisms that lead to cocaine addiction. The latest article by Dr. Marco Leyton, of the Montreal Neurological Institute (MNI), McGill University and the McGill University Health Centre, which
Thu., May 7, 2009
Cell’s split personality is a major discovery into neurological diseases
Researchers at the Université de Montreal (UdeM) and the Montreal Neurological Institute (MNI), McGill University have discovered that cells which normally support nerve cell (neuron) survival also play an active and major role in the death of neurons in the eye. The findings, published this week in The Journal of Neuroscience, may lead to more streamlined therapies for a variety of acute and... Read more
Wed., April 1, 2009
April is Parkinson’s Month
Did you know that: • Approximately 100, 000 Canadians have Parkinson’s disease. • Symptoms of Parkinson’s disease generally appear around the age of 60, although they can also occur in younger people. • Parkinson’s disease was first described in 1817 by Dr. James Parkinson, a British physician, after whom the disease was named.
Wed., March 25, 2009
When it comes to intelligence, size matters
A collaborative study led by researchers at the Montreal Neurological Institute (MNI), McGill University has demonstrated a positive link between cognitive ability and cortical thickness in the brains of healthy 6 to 18 year olds. The correlation is evident in regions that integrate information from different parts of the brain. The imaging study published this week in a special issue of scientifi
Mon., March 9, 2009
Epilepsy Awareness Month - March
Seizure-induced brain damage in epileptic patients: A new study published in Neurology by Dr. Neda Bernasconi and colleagues, reveals that patients with medication-resistant temporal lobe epilepsy (TLE), have progressive atrophy, or loss of cells, in some regions of the brain. This cortical atrophy is distinct from normal aging and likely represents seizure-induced damage. Whether recurrent ep
Fri., February 13, 2009
Brain Bee 2009
Montreal’s collective IQ will surge today as high-school students from across the city meet to compete in the 2009 Montreal regional Brain Bee competition. This exciting challenge tests for knowledge of the brain and neuroscience. The Montreal Neurological Institute (MNI), McGill University hosts the competition and graduate students from the institute have been instrumental in mentoring and... Read more
Tue., January 27, 2009
What happens when we sleep
Lack of sleep is a common complaint but for many, falling asleep involuntarily during the day poses a very real and dangerous problem.
Thu., December 11, 2008
What you give, might not always be received
A fundamental process in the transmission of genes from mother to child has been identified by researchers at the Montreal Neurological Institute, McGill University. The new study published in the December issue of the journal Nature Genetics identifies a mechanism that plays a key role in how mutations are transmitted from one generation to the next, providing unprecedented insight into metabolic
Wed., November 12, 2008
In the war against diseases, nerve cells need their armour
In a new study, researchers at the Montreal Neurological Institute (MNI), McGill University, and the Université de Montréal have discovered an essential mechanism for the maintenance of the normal structure of myelin, the protective covering that insulates and supports nerve cells (neurons).
Wed., August 6, 2008
Students invited to test their musical prowess
New study from researchers at International Laboratory for Brain, Music and Sound Research targets undergrads
Wed., July 9, 2008
Two icons of neuroscience turn 90
Dr. Brenda Milner and Dr. William Feindel, pioneers in the world of science and medicine are both turning 90 years old this week and continue to advance knowledge and understanding of the brain at the Montreal Neurological Institute.
Mon., June 2, 2008
Finding clues for nerve cell repair
A new study from the MNI at McGill University identifies a key mechanism for the normal development of motor nerve cells - cells that control muscles. This finding is crucial to understanding and treating a range of conditions involving nerve cell loss or damage, from spinal cord injury to neurodegenerative diseases such as ALS.
Thu., April 10, 2008
Improving quality of life for brain tumour patients
A new neuroimaging study at the Montreal Neurological Institute and Hospital at McGill University aims to ensure the highest quality of life for patients by assessing their cognitive skills before, during, and after brain tumour surgery.
Mon., October 1, 2007
MNI launches largest campaign in 73 years
5 years, $40 million
Mon., October 1, 2007
In memory of the past, in honour of the future
The Cyril & Dorothy and Joel & Jill Reitman Family Foundation donates $1 million to the MNI
Thu., March 22, 2007
Montreal Neurological Institute receives $15-million in federal support
The Montreal Neurological Institute (MNI) at McGill University was named a Centre of Excellence in Commercialization and Research in the newly tabled federal Budget 2007.
Mon., November 27, 2006
Partners in Neuroscience – across the globe
The Montreal Neurological Institute at McGill University partners with India's National Brain Research Centre
Montreal Neurological Institute and Hospital
3801 University Street, Montreal, Quebec, Canada H3A 2B4
Copyright © 2007-2010
| A Killam Institution |  |